Advertisement
Longeveron Inc.

Longeveron Inc. Fundamental Analysis

LGVNNASDAQ
HealthcareBiotechnology
$0.77
$0.02(2.20%)
U.S. Market is Open · 15:29
Advertisement

Longeveron Inc. Fundamental Analysis

Longeveron Inc. (LGVN) shows weak financial fundamentals with a PE ratio of -0.85, profit margin of -18.44%, and ROE of -2.02%. The company generates $0.0B in annual revenue with weak year-over-year growth of -49.87%.

Key Strengths

Cash Position80.68%
PEG Ratio-0.01
Current Ratio3.88

Areas of Concern

ROE-2.02%
Operating Margin-18.82%
We analyze LGVN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1607.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1607.2/100

We analyze LGVN's fundamental strength across five key dimensions:

Efficiency Score

Weak

LGVN struggles to generate sufficient returns from assets.

ROA > 10%
-1.06%

Valuation Score

Excellent

LGVN trades at attractive valuation levels.

PE < 25
-0.85
PEG Ratio < 2
-0.01

Growth Score

Weak

LGVN faces weak or negative growth trends.

Revenue Growth > 5%
-49.87%
EPS Growth > 10%
-20.56%

Financial Health Score

Excellent

LGVN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
3.88

Profitability Score

Weak

LGVN struggles to sustain strong margins.

ROE > 15%
-202.41%
Net Margin ≥ 15%
-18.44%
Positive Free Cash Flow
No

Key Financial Metrics

Is LGVN Expensive or Cheap?

P/E Ratio

LGVN trades at -0.85 times earnings. This suggests potential undervaluation.

-0.85

PEG Ratio

When adjusting for growth, LGVN's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Longeveron Inc. at 1.19 times its book value. This may indicate undervaluation.

1.19

EV/EBITDA

Enterprise value stands at -1.40 times EBITDA. This is generally considered low.

-1.40

How Well Does LGVN Make Money?

Net Profit Margin

For every $100 in sales, Longeveron Inc. keeps $-18.44 as profit after all expenses.

-18.44%

Operating Margin

Core operations generate -18.82 in profit for every $100 in revenue, before interest and taxes.

-18.82%

ROE

Management delivers $-2.02 in profit for every $100 of shareholder equity.

-2.02%

ROA

Longeveron Inc. generates $-1.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.06%

Following the Money - Real Cash Generation

Operating Cash Flow

Longeveron Inc. generates limited operating cash flow of $-14.73M, signaling weaker underlying cash strength.

$-14.73M

Free Cash Flow

Longeveron Inc. generates weak or negative free cash flow of $-14.96M, restricting financial flexibility.

$-14.96M

FCF Per Share

Each share generates $-0.75 in free cash annually.

$-0.75

FCF Yield

LGVN converts -1.21% of its market value into free cash.

-1.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.85

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

12.63

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.88

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.02

vs 25 benchmark

ROA

Return on assets percentage

-1.06

vs 25 benchmark

ROCE

Return on capital employed

-1.36

vs 25 benchmark

How LGVN Stacks Against Its Sector Peers

MetricLGVN ValueSector AveragePerformance
P/E Ratio-0.8529.34 Better (Cheaper)
ROE-202.41%688.00% Weak
Net Margin-1844.49%-52372.00% (disorted) Weak
Debt/Equity0.050.49 Strong (Low Leverage)
Current Ratio3.884.37 Strong Liquidity
ROA-105.75%-20476.00% (disorted) Weak

LGVN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Longeveron Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-97.96%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

41.47%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

24.34%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ